CASTRATE RESISTANT PROSTATE CANCER
Clinical trials for CASTRATE RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Prostate cancer study on race and drug response pulled before starting
Disease control TerminatedThis study aimed to see if a person's race changes how well a combination of two drugs (niraparib and abiraterone acetate plus prednisone) works for a certain type of advanced prostate cancer. It planned to enroll Black, Hispanic, White, and Native American men whose cancer had s…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated May 17, 2026 09:20 UTC
-
New radiation therapy aims to control Hard-to-Treat prostate cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a new treatment called 177Lu-HTK03170 for men with a type of advanced prostate cancer that has stopped responding to hormone therapy. The treatment delivers radiation directly to cancer cells using a targeting molecule. The goal is to find a safe dose and see if …
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Which prostate cancer drug is kinder to your brain?
Knowledge-focused OngoingThis study looks at how two different prostate cancer medications, darolutamide and enzalutamide, affect thinking skills like memory and attention. About 111 men with advanced prostate cancer will take one of the two drugs and complete computer-based brain tests over time. The go…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC